ANACOR PHARMACEUTICALS INC Inactive Instrument
Anacor Pharmaceuticals Inc Stock
Equities
US0324201013
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 2016 | Anacor Pharmaceuticals : received rival bid before Pfizer deal - filing | RE |
| 2016 | Anacor Pharmaceuticals : Pfizer to buy Anacor in $5.2 billion deal for access to eczema gel | RE |
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Douglas Giordano
CEO | Chief Executive Officer | 61 | 16-06-23 |
| Chief Tech/Sci/R&D Officer | 77 | 04-01-31 | |
| Director/Board Member | - | 16-06-23 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Douglas Giordano
CEO | Chief Executive Officer | 61 | 16-06-23 |
Bryan Supran
BRD | Director/Board Member | - | 16-06-23 |
| Director/Board Member | - | 16-06-23 |
| 1st Jan change | Capi. | |
|---|---|---|
| +4.09% | 43.43B | |
| +47.81% | 41.69B | |
| +9.45% | 41.31B | |
| -10.92% | 27.14B | |
| +9.32% | 25.28B | |
| -24.87% | 18.47B | |
| +29.70% | 12.59B | |
| +1.28% | 12.33B | |
| +7.78% | 11.03B |
- Stock Market
- Equities
- Stock
